(Q74044270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M R Michaelides

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J F Dellaria

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Gong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J H Holms

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J J Bouska

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Stacey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C K Wada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H R Heyman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M L Curtin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Y Guo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C L Goodfellow

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

I B Elmore

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D H Albert

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T J Magoc

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P A Marcotte

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D W Morgan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S K Davidsen

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1553-1556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900031-2

7 January 2021

N-formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900031-2

7 January 2021

Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900031-2

7 January 2021

Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900031-2

7 January 2021

10.1016/S0960-894X(01)00031-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412979%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference